TOT BIOPHARM International Company Limited

HKEX:1875.HK

2 (HKD) • At close September 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22018 Q12017 Q42017 Q22017 Q12016 Q4
Operating Activities:
Net Income -22.594-15.163-34.192-15.724-146.211-115.005-159.315-129.183-183.614-115.686-74.825-67.066-67.066-67.066-37.172-37.172-37.172
Depreciation & Amortization 23.47317.82718.54117.8817.15615.94515.67315.55313.69813.0896.8383.9143.9143.9143.3743.3743.374
Deferred Income Tax 0042.28600000-6.312.2350000000
Stock Based Compensation 10.643016.11106.15015.832023.5575.8895.8896.4196.4196.4190.0920.0920.092
Change In Working Capital -92.5080-40.5890-75.18602.7180-32.066-8.124-8.1245.345.345.34-6.18-6.18-6.18
Accounts Receivables -82.5490-36.2780-20.231010.1030-5.10200000000
Change In Inventory -31.1880-65.2630-21.44407.1360-12.145-3.036-3.036-0.531-0.531-0.531-0.245-0.245-0.245
Change In Accounts Payables 00000000000000000
Other Working Capital 21.229060.9520-33.5110-14.5210-14.819-5.088-5.0885.8715.8715.871-5.935-5.935-5.935
Other Non Cash Items 75.00459.74971.20626.696116.5785.436-31.0766.68251.062-21.3697.397.1857.1857.18510.53910.53910.539
Operating Cash Flow -5.98262.41331.07728.852-81.513-93.624-156.168-106.948-127.363-123.966-62.832-44.208-44.208-44.208-29.347-29.347-29.347
Investing Activities:
Investments In Property Plant And Equipment -71.505-125.776-181.108-57.872-57.143-55.146.69-27.177-19.275-17.011-9.335-19.55-19.55-19.55-33.671-33.671-33.671
Acquisitions Net 0-3.8180.0940000003.4450000000
Purchases Of Investments 0-320.06-279.91000000-32.95-32.95-29.125-29.125-29.125-15.075-15.075-15.075
Sales Maturities Of Investments 0366.672241.95800000029.50529.50536.90836.90836.90821.00721.00721.007
Other Investing Activites -7.85241.028-38.245-5.5394.26-0.37241.627-208.614-3.98-10.83612.7811.76711.76711.76727.73927.73927.739
Investing Cash Flow -79.357-84.748-219.353-63.411-52.883-55.51248.317-235.791-23.255-27.847-12.78-11.767-11.767-11.767-27.739-27.739-27.739
Financing Activities:
Debt Repayment 0-39.645-44.774-37.9940-71.3270-61.180-1.074-0.125-17.048-17.048-17.048000
Common Stock Issued 00453.984000000135.488135.488000000
Common Stock Repurchased 00000000000000000
Dividends Paid 00000000000000000
Other Financing Activities 4.14-5.56447.857-4.611131.1459.6117.692-18.219529.21154.885-135.36317.04817.04817.048000
Financing Cash Flow 4.1434.085447.85733.383131.14580.93717.692-79.399529.21153.811131.151-17.41-17.41-17.41000
Other Information:
Effect Of Forex Changes On Cash -0.1763.4563.3123.247-0.187-1.0932.183-3.5333.453-1.61515.069131.427131.427131.427000
Net Change In Cash 0-39.437317.5362.071-3.438-69.29112.024-425.671382.04692.94670.60758.04358.04358.0431.1341.1341.134
Cash At End Of Period 432.975432.975472.412154.876152.805156.243225.533113.509539.18157.134134.79564.18864.18864.1886.1456.1456.145